Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302028439> ?p ?o ?g. }
- W4302028439 abstract "African swine fever virus (ASFV) causes significant morbidity and mortality in pigs worldwide. The lack of vaccines or therapeutic options warrants urgent further investigation. To this aim, we developed a rationally designed live attenuated ASFV-Δ110-9L/505-7R mutant based on the highly pathogenic Genotype II ASFV CN/GS/2018 backbone by deleting 2 well-characterized interferon inhibitors MGF110-9L and MGF505-7R. The mutant was slightly attenuated in vitro compared to parental ASFV but highly tolerant to genetic modifications even after 30 successive passages in vitro. Groups of 5 pigs were intramuscularly inoculated with increasing doses of the mutant, ranging from 103 to 106 hemadsorption units (HAD50). Thirty-five days later, all groups were challenged with 102 HAD50 of virulent parental ASFV. All the animals were clinically normal and devoid of clinical signs consistent with ASFV at the period of inoculation. In the virulent challenge, 2 animals from 103 HAD50-inoculated group and 1 animal from 104 HAD50-inoculated group were unprotected with severe postmortem and histological lesions. The rest of animals survived and manifested with relatively normal clinical appearance accompanied by tangible histological improvements in the extent of tissue damage. Meanwhile, antibody response, as represented by p30-specific antibody titers was positively correlated to protective efficacy, potentializing its usage as an indicator of protection. Moreover, compared to 1 dose, 2 doses provided additional protection, proving that 2 doses were better than 1 dose. The sufficiency in effectiveness supports the claim that our attenuated mutant may be a viable vaccine option with which to fight ASF. IMPORTANCE African swine fever virus (ASFV) is a causative agent of acute viral hemorrhagic disease of domestic swine which is associated with significant economic losses in the pig industry. The lack of vaccines or treatment options requires urgent further investigation. ASFV MGF110-9L and MGF505-7R, 2 well-characterized interferon inhibitors, were associated with viral virulence, host range, and immune modulation. In this study, a recombinant two-gene deletion ASFV mutant with deletion of MGF110-9L and MGF505-7R was constructed. The result showed that the mutant was safe, and also highly resistant to genetic modification even after 30 successive passages. High doses of our mutant (105 and 106 HAD50) provided sterile immunity and complete protection in a virulent challenge. Two doses were superior to 1 dose and provided additional protection. This study develops a new ASFV-specific live attenuated vaccine and may be a viable vaccine option against ASF." @default.
- W4302028439 created "2022-10-06" @default.
- W4302028439 creator A5002429812 @default.
- W4302028439 creator A5013569761 @default.
- W4302028439 creator A5017055713 @default.
- W4302028439 creator A5021104040 @default.
- W4302028439 creator A5034859968 @default.
- W4302028439 creator A5042855183 @default.
- W4302028439 creator A5046119738 @default.
- W4302028439 creator A5046409001 @default.
- W4302028439 creator A5068492937 @default.
- W4302028439 creator A5079839228 @default.
- W4302028439 creator A5084603057 @default.
- W4302028439 creator A5086868805 @default.
- W4302028439 date "2022-10-26" @default.
- W4302028439 modified "2023-10-05" @default.
- W4302028439 title "Sequential Deletions of Interferon Inhibitors MGF110-9L and MGF505-7R Result in Sterile Immunity against the Eurasia Strain of Africa Swine Fever" @default.
- W4302028439 cites W1970424608 @default.
- W4302028439 cites W2016158866 @default.
- W4302028439 cites W2055429537 @default.
- W4302028439 cites W2067351227 @default.
- W4302028439 cites W2076635920 @default.
- W4302028439 cites W2087601007 @default.
- W4302028439 cites W2092339835 @default.
- W4302028439 cites W2112078441 @default.
- W4302028439 cites W2146137488 @default.
- W4302028439 cites W2171126517 @default.
- W4302028439 cites W2215484003 @default.
- W4302028439 cites W227587478 @default.
- W4302028439 cites W2430425211 @default.
- W4302028439 cites W2465244983 @default.
- W4302028439 cites W2516142551 @default.
- W4302028439 cites W2532108477 @default.
- W4302028439 cites W2540080277 @default.
- W4302028439 cites W2581097550 @default.
- W4302028439 cites W2613902351 @default.
- W4302028439 cites W2750227535 @default.
- W4302028439 cites W2757191286 @default.
- W4302028439 cites W2786046566 @default.
- W4302028439 cites W2789695849 @default.
- W4302028439 cites W2912706118 @default.
- W4302028439 cites W2950452540 @default.
- W4302028439 cites W2955469799 @default.
- W4302028439 cites W2963430002 @default.
- W4302028439 cites W2966891866 @default.
- W4302028439 cites W2981124349 @default.
- W4302028439 cites W2999006774 @default.
- W4302028439 cites W3002659938 @default.
- W4302028439 cites W3009223043 @default.
- W4302028439 cites W3028544720 @default.
- W4302028439 cites W3097432845 @default.
- W4302028439 cites W3111481004 @default.
- W4302028439 cites W3126080089 @default.
- W4302028439 cites W3127250530 @default.
- W4302028439 cites W3162198836 @default.
- W4302028439 cites W3164297818 @default.
- W4302028439 cites W3183890848 @default.
- W4302028439 cites W3193330753 @default.
- W4302028439 cites W3196203393 @default.
- W4302028439 cites W3199420529 @default.
- W4302028439 cites W3209566925 @default.
- W4302028439 cites W326745324 @default.
- W4302028439 cites W4250866932 @default.
- W4302028439 cites W4283824504 @default.
- W4302028439 doi "https://doi.org/10.1128/jvi.01192-22" @default.
- W4302028439 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36197109" @default.
- W4302028439 hasPublicationYear "2022" @default.
- W4302028439 type Work @default.
- W4302028439 citedByCount "8" @default.
- W4302028439 countsByYear W43020284392022 @default.
- W4302028439 countsByYear W43020284392023 @default.
- W4302028439 crossrefType "journal-article" @default.
- W4302028439 hasAuthorship W4302028439A5002429812 @default.
- W4302028439 hasAuthorship W4302028439A5013569761 @default.
- W4302028439 hasAuthorship W4302028439A5017055713 @default.
- W4302028439 hasAuthorship W4302028439A5021104040 @default.
- W4302028439 hasAuthorship W4302028439A5034859968 @default.
- W4302028439 hasAuthorship W4302028439A5042855183 @default.
- W4302028439 hasAuthorship W4302028439A5046119738 @default.
- W4302028439 hasAuthorship W4302028439A5046409001 @default.
- W4302028439 hasAuthorship W4302028439A5068492937 @default.
- W4302028439 hasAuthorship W4302028439A5079839228 @default.
- W4302028439 hasAuthorship W4302028439A5084603057 @default.
- W4302028439 hasAuthorship W4302028439A5086868805 @default.
- W4302028439 hasBestOaLocation W43020284391 @default.
- W4302028439 hasConcept C104317684 @default.
- W4302028439 hasConcept C105702510 @default.
- W4302028439 hasConcept C143065580 @default.
- W4302028439 hasConcept C159047783 @default.
- W4302028439 hasConcept C159654299 @default.
- W4302028439 hasConcept C180032290 @default.
- W4302028439 hasConcept C202751555 @default.
- W4302028439 hasConcept C203014093 @default.
- W4302028439 hasConcept C2522874641 @default.
- W4302028439 hasConcept C2776178377 @default.
- W4302028439 hasConcept C2778022156 @default.
- W4302028439 hasConcept C2778359420 @default.
- W4302028439 hasConcept C2779341262 @default.
- W4302028439 hasConcept C32611913 @default.
- W4302028439 hasConcept C54355233 @default.